Literature DB >> 11389905

Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions.

M Klinkenberg1, S Van Huffel, K Heyninck, R Beyaert.   

Abstract

The tumor necrosis factor (TNF) inducible protein A20 is a potent inhibitor of nuclear factor-kappaB (IkappaB)-mediated gene expression in response to TNF and several other stimuli. The C-terminal domain of A20 is characterized by seven zinc finger structures. Here, we show that a minimum of four zinc fingers is required to inhibit TNF-induced nuclear factor-kappaB (NF-kappaB) activation to a level that is comparable to that obtained with the wild-type A20 protein. However, there was no strict requirement for a particular zinc finger structure, since a mutant A20 protein containing only the first four zinc fingers was as potent as a mutant protein containing only the last four zinc fingers. A similar functional redundancy of the A20 zinc fingers was also observed for binding of A20 to a number of other proteins, including two novel NF-kappaB inhibitory proteins (ABIN-1, ABIN-2), A20 itself, the anti-apoptotic protein TXBP151, and a regulatory component of the IkappaB kinase complex, IKKgamma. Moreover, we demonstrate that complete loss of binding of any of these proteins correlates with complete loss of A20's ability to inhibit TNF-induced NF-kappaB activation. However, binding of IKKgamma as such is not sufficient for inhibition of NF-kappaB dependent gene expression in response to TNF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389905     DOI: 10.1016/s0014-5793(01)02504-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

Review 1.  A20: central gatekeeper in inflammation and immunity.

Authors:  Beatrice Coornaert; Isabelle Carpentier; Rudi Beyaert
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

Review 2.  Linear polyubiquitination: a new regulator of NF-kappaB activation.

Authors:  Kazuhiro Iwai; Fuminori Tokunaga
Journal:  EMBO Rep       Date:  2009-06-19       Impact factor: 8.807

Review 3.  A20: from ubiquitin editing to tumour suppression.

Authors:  Sarah G Hymowitz; Ingrid E Wertz
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

4.  SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.

Authors:  Sebastian A Wagner; Shankha Satpathy; Petra Beli; Chunaram Choudhary
Journal:  EMBO J       Date:  2016-06-15       Impact factor: 11.598

Review 5.  Regulation of NF-κB signaling by the A20 deubiquitinase.

Authors:  Noula Shembade; Edward W Harhaj
Journal:  Cell Mol Immunol       Date:  2012-02-20       Impact factor: 11.530

6.  Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).

Authors:  Arantza Azpilikueta; Elixabet Bolaños; Valerie Lang; Sara Labiano; Maria A Aznar; Iñaki Etxeberria; Alvaro Teijeira; Maria E Rodriguez-Ruiz; Jose L Perez-Gracia; Maria Jure-Kunkel; Juan M Zapata; Manuel S Rodriguez; Ignacio Melero
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

7.  Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.

Authors:  Fuminori Tokunaga; Hiroshi Nishimasu; Ryuichiro Ishitani; Eiji Goto; Takuya Noguchi; Kazuhiro Mio; Kiyoko Kamei; Averil Ma; Kazuhiro Iwai; Osamu Nureki
Journal:  EMBO J       Date:  2012-08-28       Impact factor: 11.598

8.  A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.

Authors:  Kai-Li He; Adrian T Ting
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation.

Authors:  Lianyun Li; Nia Soetandyo; Qiuyan Wang; Yihong Ye
Journal:  Biochim Biophys Acta       Date:  2008-10-08

10.  Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.

Authors:  Su-Chang Lin; Jee Y Chung; Betty Lamothe; Kanagalaghatta Rajashankar; Miao Lu; Yu-Chih Lo; Amy Y Lam; Bryant G Darnay; Hao Wu
Journal:  J Mol Biol       Date:  2007-12-04       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.